Quantitative 31 P-NMR for Purity Determination of Organophosphorus Compounds (Pharmaceuticals)

Nahoko Uchiyama
DOI: https://doi.org/10.1248/yakushi.23-00151-3
2024-04-01
YAKUGAKU ZASSHI
Abstract:Quantitative NMR (qNMR), particularly <sup>1</sup>H-qNMR, is useful for determining the absolute purity of organic molecules. However, identifying the target signal(s) for quantification is difficult, because of the overlap and complexity of organic molecules. Therefore, we focused on the <sup>31</sup>P nucleus, owing to the simplicity of its signals, and investigated the <sup>31</sup>P-qNMR absolute determination method by using organophosphorus drugs, water-soluble cyclophosphamide hydrate (CP), and water-insoluble sofosbuvir (SOF). The optimized and reproducible <sup>31</sup>P-qNMR conditions, such as qNMR sample preparation [i.e., selecting suitable deuterated solvents and a reference standard (RS) for <sup>31</sup>P-qNMR], hygroscopicity and solution stability of the analyte and RS, and qNMR measurements-such as acquisition time, relaxation delay time, and spectral width-were examined. The CP purities determined using <sup>31</sup>P-qNMR agreed well with those for the established <sup>1</sup>H-qNMR method in D<sub>2</sub>O. In contrast, the SOF purity determined using <sup>31</sup>P-qNMR was 1.6% higher than that for <sup>1</sup>H-qNMR in the protic solvent CD<sub>3</sub>OD. Therefore, using a protic solvent, such as CD<sub>3</sub>OD, was not suitable for <sup>31</sup>P-qNMR; the deuterium exchange with the RS for <sup>31</sup>P-qNMR (i.e., phosphonoacetic acid) resulted in a small integrated intensity. Consequently, the aprotic solvent DMSO-d<sub>6</sub> was employed to determine the SOF purity. The data revealed that the SOF purities determined using <sup>31</sup>P-qNMR agreed well with the established <sup>1</sup>H-qNMR values, indicating that the absolute quantification of SOF using both <sup>31</sup>P-qNMR and <sup>1</sup>H-qNMR is possible in DMSO-d<sub>6</sub>. Thus, we established an optimized and reproducible <sup>31</sup>P-qNMR method in validation study across multiple laboratories.
pharmacology & pharmacy
What problem does this paper attempt to address?